Cardopa Injection contains Dopamine Hydrochloride, a potent sympathomimetic agent used primarily for cardiovascular support in critical care settings. This injectable solution is formulated at a concentration of 200 mg/5 ml, ensuring precise dosing for acute management of hypotension, shock, and heart failure.

Dopamine, the active ingredient in Cardopa, acts on specific adrenergic and dopaminergic receptors, producing dose-dependent effects. At lower doses, it stimulates dopaminergic receptors, leading to renal vasodilation, which enhances renal perfusion and promotes diuresis. This mechanism is particularly beneficial in patients with compromised kidney function or those at risk of acute renal failure.

At moderate doses, dopamine predominantly activates β1-adrenergic receptors in the heart, resulting in increased cardiac output and enhanced myocardial contractility. This effect makes Cardopa Injection valuable in managing patients with heart failure or cardiogenic shock, where improved cardiac performance is critical for survival.

At higher doses, dopamine stimulates α-adrenergic receptors, causing vasoconstriction, which helps raise systemic blood pressure in cases of severe hypotension or septic shock. This dose-dependent receptor activity allows clinicians to tailor therapy according to the patient’s hemodynamic status.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features and Benefits

• Potent Cardiovascular Support: Improves heart contractility and blood pressure in critically ill patients.
• Renal Protection: Low-dose dopamine enhances renal blood flow, supporting kidney function.
• Flexible Dosing: Allows targeted therapy based on receptor-specific responses.
• Rapid Onset: Provides quick therapeutic effects, essential in acute care scenarios.
• Sterile Injectable Formulation: Ensures safe and reliable administration in hospital settings.

Indications

Cardopa Injection is indicated for:

• Acute hypotension and shock.
• Cardiogenic shock post-myocardial infarction.
• Heart failure requiring inotropic support.
• Renal perfusion improvement in critically ill patients.

Administration

Cardopa should be administered intravenously under continuous monitoring, preferably in an intensive care or critical care setting. The dosage is determined based on patient condition, desired hemodynamic effect, and response to therapy. Close monitoring of blood pressure, heart rate, and urine output is recommended during administration.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety Information

• Use cautiously in patients with tachyarrhythmias, hypertension, or pheochromocytoma.
• Continuous monitoring is essential to avoid adverse effects such as arrhythmias, excessive vasoconstriction, or tissue necrosis at the injection site.
• Follow institutional protocols for dilution and infusion to minimize complications.

Storage

Store Cardopa Injection at 2–8°C. Protect from light and do not freeze. Ensure the solution is clear and free from particulate matter before administration.